Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

GLATIRAMER ACETATE

GLATIRAMER ACETATE

Standard Dose
40MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GLATIRAMER ACETATE is listed in Drugs@FDA under application 214741 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GLATIRAMER ACETATE Form and strength INJECTABLE;SUBCUTANEOUS - 40MG/ML Sponsor SCINOPHARM TAIWAN Submission history Latest submission status date: 2025-12-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLATIRAMER ACETATE is listed in Drugs@FDA under application 214741 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GLATIRAMER ACETATE Form and strength INJECTABLE;SUBCUTANEOUS - 40MG/ML Sponsor SCINOPHARM TAIWAN Submission history Latest submission status date: 2025-12-31 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.